SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : POSITIVE EARNINGS

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: ~digs7/1/2007 8:32:49 AM
   of 337
 
IAGX.OB (imagenetix inc) last: 1.49 +0.24 19.20% (Vol: 298923) Daily Range: (1.30-1.50)

Imagenetix, Inc. engages in the development, formulation, and marketing of over-the-counter nutritional supplements, topical creams, and skin care products on a private label basis primarily in the United States. Its primary product is Celadrin, a nutritional supplement compound comprised of fatty acid esters, which play a role in human and animal joint health. Celadrin is offered as a part of product formulations on a private label basis and also as an ingredient to be used by the company's customers in their own products. The company also develops other natural based products designed to address specific health issues, including compounds and formulations involving a proprietary blend of fruit and vegetable extracts.

Thursday June 28, 2:29 pm ET
Imagenetix Reports Fourth Quarter and Year-End Results
- Fourth Quarter Revenues Increases More Than 120% From Prior Year
- Fourth Quarter Net Income Before Tax $107,000 Versus Loss of $990,000 in Same Period Last Year
- Sees Solid Gains in Sales and Profits in Fiscal 2008
biz.yahoo.com


Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext